Spots Global Cancer Trial Database for zoladex
Every month we try and update this database with for zoladex cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Prospective, Single-Arm Study to Evaluate the Efficacy and Safety of Zoladex 3.6mg Combined With CEF Chemotherapy as Neo-Adjuvant Therapy in Hormone Responsive, Premenopausal, Operable Breast Cancer | NCT00488722 | Breast Cancer | Zoladex | 25 Years - 50 Years | Tianjin Medical University | |
| Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer | NCT02749825 | Prostate Cancer | Trelstar Lupron Zoladex | 18 Years - | Pharmatech | |
| Ipilimumab + Androgen Depravation Therapy in Prostate Cancer | NCT01377389 | Prostate Cancer | Ipilimumab Leuprolide Goserelin Degarelix | 18 Years - | M.D. Anderson Cancer Center | |
| A Study to Assess LY01005 Versus Goserelin Comparator (ZOLADEX®) in Patients With Prostate Cancer | NCT03450109 | Cancer of Prost... | LY01005 Zoladex | 18 Years - | Luye Pharma Group Ltd. | |
| Fulvestrant in Metastatic Breast Cancer | NCT03591549 | Metastatic Brea... | Faslodex Zoladex | 30 Years - 55 Years | Assiut University | |
| External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer | NCT00388804 | Prostate Cancer | Radiation Thera... Bicalutamide Leuprolide Goserelin Flutamide Questionnaire | - | M.D. Anderson Cancer Center | |
| Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer | NCT00631527 | Prostate Cancer | Leuprolide Goserelin Sunitinib Malat... Casodex Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer | NCT02749825 | Prostate Cancer | Trelstar Lupron Zoladex | 18 Years - | Pharmatech | |
| Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle | NCT00586898 | Prostate Cancer Hormonal Cyclin... | GnRH Ketoconazole Bicalutamide Testosterone tr... Estrogen transd... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Study to Compare Zoladex™ 10.8 mg With Zoladex 3.6 mg in Pre-menopausal Women With Breast Cancer | NCT01073865 | Breast Cancer | ZD9393 (Zoladex... ZD9393 (Zoladex... | 20 Years - 130 Years | AstraZeneca | |
| Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomy | NCT00850941 | Prostate Cancer | Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
| Fulvestrant in Metastatic Breast Cancer | NCT03591549 | Metastatic Brea... | Faslodex Zoladex | 30 Years - 55 Years | Assiut University | |
| Evaluation of QoL, Tolerability and Use of Zoladex 10,8 SafeSystem for Advanced PCa - German IPEP Trial | NCT00540059 | Prostate Carcin... | - | AstraZeneca | ||
| Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer | NCT02749825 | Prostate Cancer | Trelstar Lupron Zoladex | 18 Years - | Pharmatech | |
| Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate Cancer | NCT00658697 | Prostate Cancer | Docetaxel Bevacizumab ADT Bicalutamide | 18 Years - | Dana-Farber Cancer Institute | |
| To Assess The Patient Preference for Goserelin Microsphere Versus Goserelin Implant in Patients With Prostate Cancer | NCT06385847 | Prostate Cancer | Zoladex LY01005 | 18 Years - | The First Affiliated Hospital of Xiamen University | |
| To Compare ZOLADEX 10.8 mg With ZOLADEX 3.6mg in Chinese Pre-menopausal ER+ HER2- Early Breast Cancer. | NCT03658213 | Breast Cancer | ZOLADEX 10.8 mg ZOLADEX 3.6mg | 18 Years - 59 Years | AstraZeneca | |
| A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer | NCT02059213 | Prostate Cancer | Ibrance Bicalutamide Zoladex Lupron Depot | 18 Years - | University of Michigan Rogel Cancer Center | |
| Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer | NCT00002597 | Prostate Cancer | flutamide Zoladex Lupron radiation thera... | 18 Years - | Radiation Therapy Oncology Group | |
| Androgen Deprivation Therapy Muscle Protein Metabolism and Blood Glucose | NCT03440879 | Prostate Cancer Resistance Exer... Androgen Depriv... | Zoladex | 18 Years - 75 Years | Norwegian School of Sport Sciences | |
| A Prospective, Single-Arm Study to Evaluate the Efficacy and Safety of Zoladex 3.6mg Combined With CEF Chemotherapy as Neo-Adjuvant Therapy in Hormone Responsive, Premenopausal, Operable Breast Cancer | NCT00488722 | Breast Cancer | Zoladex | 25 Years - 50 Years | Tianjin Medical University | |
| A Prospective, Single-Arm Study to Evaluate the Efficacy and Safety of Zoladex 3.6mg Combined With CEF Chemotherapy as Neo-Adjuvant Therapy in Hormone Responsive, Premenopausal, Operable Breast Cancer | NCT00488722 | Breast Cancer | Zoladex | 25 Years - 50 Years | Tianjin Medical University | |
| Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer | NCT01250717 | Prostate Cancer | Docetaxel Dexamethasone Estramustine Zoladex Casodex Radical Prostat... | 18 Years - | Dana-Farber Cancer Institute | |
| To Compare ZOLADEX 10.8 mg With ZOLADEX 3.6mg in Chinese Pre-menopausal ER+ HER2- Early Breast Cancer. | NCT03658213 | Breast Cancer | ZOLADEX 10.8 mg ZOLADEX 3.6mg | 18 Years - 59 Years | AstraZeneca | |
| Simultaneous Versus Sequential Use of Adjuvant Chemotherapy and GnRHa in Treating ER+,Premenopausal Breast Cancer | NCT01712893 | Breast Cancer | Zoladex | - 45 Years | Fudan University | |
| Ipilimumab + Androgen Depravation Therapy in Prostate Cancer | NCT01377389 | Prostate Cancer | Ipilimumab Leuprolide Goserelin Degarelix | 18 Years - | M.D. Anderson Cancer Center | |
| Adjuvant AI Combined With Zoladex | NCT01352091 | Breast Cancer | Zoladex+AI TAM | 18 Years - | Fudan University | |
| Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer | NCT00500110 | Prostate Cancer | Docetaxel Imatinib Mesyla... Leuprolide Goserelin Aceta... | - | M.D. Anderson Cancer Center | |
| A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer | NCT02059213 | Prostate Cancer | Ibrance Bicalutamide Zoladex Lupron Depot | 18 Years - | University of Michigan Rogel Cancer Center | |
| External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer | NCT00388804 | Prostate Cancer | Radiation Thera... Bicalutamide Leuprolide Goserelin Flutamide Questionnaire | - | M.D. Anderson Cancer Center | |
| Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment | NCT00165399 | Adenocarcinoma ... Prostate Cancer | Docetaxel Estramustine Casodex Zoladex | 18 Years - | Dana-Farber Cancer Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
